Example: biology

Q4 2021 Results

Balance sheet strength & strong cash flow generation • $17B total cash as of YE • Gross debt reduction of ~$6.1B • 10.2% dividend growth: 13th consecutive annual increase • $5B ASR to be executed in Q1’22 as part of $15B share repurchase authorization • 2022 guidance reflects Revenue & Non-GAAP EPS growth 2021 Performance 4

Tags:

  Balance

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Related search queries